April 19, 2021April 19, 2021
Pulmatrix Regains Rights to PUR1800 for COPD, Phase 2 Trial Planned
News
Pulmatrix will regain full rights to its portfolio of narrow spectrum kinase inhibitor (NSKI) medications, including the investigational therapy ... Read more
April 15, 2021April 15, 2021
COPD Patients Often Treated for Depression and Anxiety, Study Finds
News
Antidepressants and anti-anxiety medications are often prescribed to people with chronic obstructive pulmonary disease (COPD), pointing to a higher ... Read more
April 12, 2021April 12, 2021
Respinova Wins FDA OK for Airway Opening System Pulsehaler
News
Respinova’s new airway device, called Pulsehaler, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). That ... Read more
April 8, 2021April 8, 2021
FDA Approval Sought for New Generic Version of Advair Diskus
News
Lannett is seeking the approval of a generic form of Advair Diskus (fluticasone-salmeterol powder) in the U.S. Such an approval ... Read more
April 5, 2021April 5, 2021
Study of Lung Health Among Blacks Earns CHEST Foundation Grant
News
Researchers at the Lewis Katz School of Medicine at Temple University (LKSOM) have been awarded a $30,000 CHEST Foundation ... Read more
April 1, 2021April 1, 2021
Long-term Pulmonary Rehabilitation Can Benefit COPD Patients in Real Life
News
Long-term pulmonary rehabilitation (PR) maintenance programs can benefit people with chronic obstructive pulmonary disease (COPD) in a real-life setting, ... Read more
March 29, 2021March 29, 2021
Study Identifies COPD Complications That Increase Patient Risk
News
Patients with chronic obstructive pulmonary disease who have worse lung function and prior history of acidotic hypercapnic respiratory failure ... Read more
March 25, 2021March 25, 2021
COPD Foundation, DevPro Biopharma Partner to Boost New Therapy Development
News
The Chronic Obstructive Pulmonary Disease Foundation and DevPro Biopharma have established a partnership to develop new therapies for people with chronic obstructive pulmonary disease ... Read more
March 22, 2021March 22, 2021
Researchers Find 2 Patterns of Coexisting Disorders in Patients
News
Neurological and psychological disorders that often coexist in patients with chronic obstructive pulmonary disease (COPD) may be grouped into ... Read more
March 18, 2021March 18, 2021
Viral Infections May Lead to Chronic Lung Disease via Sentinel Immune Cells
News
In response to an acute respiratory viral infection, a type of sentinel immune cell — called dendritic cells — ... Read more
March 15, 2021March 15, 2021
Belluscura’s Portable Oxygen Concentrator Cleared for US Market
News
X-PLO₂R, a portable oxygen concentrator developed by Belluscura and its research partner Separation Design Group, has been cleared for ... Read more
March 11, 2021March 11, 2021
Researcher Will Use £500,000 Grant to Develop ‘Virtual Lung’
News
A Royal Academy of Engineering Research Fellow in the U.K. has been awarded a £500,000 (nearly $700,000) grant to ... Read more

April 19, 2021April 19, 2021

Pulmatrix Regains Rights to PUR1800 for COPD, Phase 2 Trial Planned

News

Pulmatrix will regain full rights to its portfolio of narrow spectrum kinase inhibitor (NSKI) medications, including the investigational therapy PUR1800 to treat acute flare in chronic obstructive pulmonary disease (COPD) ... Read more

April 15, 2021April 15, 2021

COPD Patients Often Treated for Depression and Anxiety, Study Finds

News

Antidepressants and anti-anxiety medications are often prescribed to people with chronic obstructive pulmonary disease (COPD), pointing to a higher risk of psychiatric and mental health problems in this patient group, ... Read more

April 12, 2021April 12, 2021

Respinova Wins FDA OK for Airway Opening System Pulsehaler

News

Respinova’s new airway device, called Pulsehaler, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). That means it can be marketed as a safe and effective medical ... Read more

April 8, 2021April 8, 2021

FDA Approval Sought for New Generic Version of Advair Diskus

News

Lannett is seeking the approval of a generic form of Advair Diskus (fluticasone-salmeterol powder) in the U.S. Such an approval would be expected to provide a less-expensive alternative to the inhalation ... Read more

April 5, 2021April 5, 2021

Study of Lung Health Among Blacks Earns CHEST Foundation Grant

News

Researchers at the Lewis Katz School of Medicine at Temple University (LKSOM) have been awarded a $30,000 CHEST Foundation Research Grant to study racial differences in lung health among smokers, with ... Read more

April 1, 2021April 1, 2021

Long-term Pulmonary Rehabilitation Can Benefit COPD Patients in Real Life

News

Long-term pulmonary rehabilitation (PR) maintenance programs can benefit people with chronic obstructive pulmonary disease (COPD) in a real-life setting, a retrospective study indicates. In fact, PR maintenance programs lasting three ... Read more

March 29, 2021March 29, 2021

Study Identifies COPD Complications That Increase Patient Risk

News

Patients with chronic obstructive pulmonary disease who have worse lung function and prior history of acidotic hypercapnic respiratory failure (AHRF) are more likely to develop hypercapnia, defined as excessive carbon ... Read more

March 25, 2021March 25, 2021

COPD Foundation, DevPro Biopharma Partner to Boost New Therapy Development

News

The Chronic Obstructive Pulmonary Disease Foundation and DevPro Biopharma have established a partnership to develop new therapies for people with chronic obstructive pulmonary disease (COPD) and other lung disorders. The collaborators will work to identify ... Read more

March 22, 2021March 22, 2021

Researchers Find 2 Patterns of Coexisting Disorders in Patients

News

Neurological and psychological disorders that often coexist in patients with chronic obstructive pulmonary disease (COPD) may be grouped into two distinct clusters or patterns, according to a recent study. Investigators ... Read more

March 18, 2021March 18, 2021

Viral Infections May Lead to Chronic Lung Disease via Sentinel Immune Cells

News

In response to an acute respiratory viral infection, a type of sentinel immune cell — called dendritic cells — trigger a chain of events that can lead to lung diseases ... Read more